Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$32.33 - $37.71 $96,731 - $112,828
2,992 Added 48.99%
9,099 $314,000
Q4 2022

Feb 14, 2023

BUY
$30.52 - $41.79 $186,385 - $255,211
6,107 New
6,107 $228,000
Q3 2021

Nov 12, 2021

SELL
$45.58 - $51.78 $199,230 - $226,330
-4,371 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$50.84 - $56.8 $222,221 - $248,272
4,371 New
4,371 $230,000
Q3 2020

Nov 10, 2020

SELL
$34.67 - $43.16 $485,969 - $604,973
-14,017 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$38.35 - $47.02 $71,100 - $87,175
-1,854 Reduced 11.68%
14,017 $594,000
Q1 2020

May 12, 2020

BUY
$41.02 - $59.59 $206,658 - $300,214
5,038 Added 46.51%
15,871 $845,000
Q4 2019

Jan 24, 2020

SELL
$52.08 - $62.72 $36,195 - $43,590
-695 Reduced 6.03%
10,833 $639,000
Q3 2019

Nov 05, 2019

SELL
$49.29 - $58.06 $4,682 - $5,515
-95 Reduced 0.82%
11,528 $638,000
Q2 2019

Jul 18, 2019

SELL
$49.34 - $63.49 $178,857 - $230,151
-3,625 Reduced 23.77%
11,623 $635,000
Q1 2019

Apr 18, 2019

SELL
$59.79 - $74.43 $484,777 - $603,478
-8,108 Reduced 34.71%
15,248 $965,000
Q4 2018

Jan 25, 2019

BUY
$65.26 - $85.69 $350,576 - $460,326
5,372 Added 29.87%
23,356 $1.6 Million
Q3 2018

Oct 17, 2018

BUY
$60.76 - $73.81 $19,017 - $23,102
313 Added 1.77%
17,984 $1.22 Million
Q2 2018

Jul 27, 2018

SELL
$59.7 - $68.0 $64,714 - $73,712
-1,084 Reduced 5.78%
17,671 $1.06 Million
Q1 2018

Apr 06, 2018

BUY
$65.43 - $80.27 $376,287 - $461,632
5,751 Added 44.22%
18,755 $1.23 Million
Q4 2017

Jan 25, 2018

SELL
$64.48 - $76.95 $117,353 - $140,049
-1,820 Reduced 12.28%
13,004 $944,000
Q3 2017

Oct 03, 2017

BUY
$77.22 - $82.74 $1.14 Million - $1.23 Million
14,824
14,824 $1.15 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $7.84B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.